These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35421593)

  • 1. Clinical Applicability of Patient- and Clinician-Reported Outcome Tools in the Management of Patients With Acromegaly.
    Herman R; Goričar K; Janež A; Jensterle M
    Endocr Pract; 2022 Jul; 28(7):678-683. PubMed ID: 35421593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly.
    Herman R; Janež A; Goričar K; Rizzo M; Jensterle M
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556914
    [No Abstract]   [Full Text] [Related]  

  • 3. International Multicenter Validation Study of the SAGIT® Instrument in Acromegaly.
    Giustina A; Bronstein MD; Chanson P; Petersenn S; Casanueva FF; Sert C; Houchard A; Melmed S
    J Clin Endocrinol Metab; 2021 Nov; 106(12):3555-3568. PubMed ID: 34313752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Questionnaire and tools: clinical powerful instrument in acromegaly diagnosis and management.
    Camerini S; Wennberg A; Adriani M; Martin B; Vettor R; Maffei P; Dassie F
    J Endocrinol Invest; 2022 Oct; 45(10):1823-1834. PubMed ID: 35322391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study.
    Sawicka-Gutaj N; Ziółkowska P; Biczysko A; Erampamoorthy A; Ziemnicka K; Ruchała M
    Sci Rep; 2023 Feb; 13(1):3286. PubMed ID: 36841880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice--development and results from a pilot study.
    Giustina A; Bevan JS; Bronstein MD; Casanueva FF; Chanson P; Petersenn S; Thanh XM; Sert C; Houchard A; Guillemin I; Melmed S;
    Pituitary; 2016 Feb; 19(1):39-49. PubMed ID: 26377024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lanreotide Autogel primary therapy on symptoms and quality-of-life in acromegaly: data from the PRIMARYS study.
    Caron PJ; Bevan JS; Petersenn S; Houchard A; Sert C; Webb SM;
    Pituitary; 2016 Apr; 19(2):149-57. PubMed ID: 26603536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between pain, arthropathy and health-related quality of life in patients suffering from acromegaly. A cross-sectional study.
    Alito A; Basile GC; Bruschetta D; Berescu GL; Cavallaro F; Postorino AD; Scarcella E; Ragonese M; Cannavò S; Tisano A
    Folia Med (Plovdiv); 2023 Feb; 65(1):37-45. PubMed ID: 36855972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
    T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
    Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acromegaly improves quality of life, measured by AcroQol.
    Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
    Webb SM; Badia X; Surinach NL;
    Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. May the SAGIT® instrument be used as a preoperative prognostic tool in patients with acromegaly?
    Gezer E; Çetinarslan B; Cantürk Z; Selek A; Sözen M; Köksalan D; Bekiroğlu A; Anik I; Ceylan S
    Minerva Endocrinol (Torino); 2022 Oct; ():. PubMed ID: 36285746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life in patients with acromegaly receiving lanreotide autogel: a real-world observational study.
    Bolanowski M; Hubalewska-Dydejczyk A; Kos-Kudła B; Ruchała M; Witek P; Zgliczyński W; Houchard A; Bartmańska M
    Endokrynol Pol; 2021; 72(5):512-519. PubMed ID: 34647602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
    Chin SO; Chung CH; Chung YS; Kim BJ; Kim HY; Kim IJ; Kim JG; Kim MS; Kim SY; Lee EJ; Lee KY; Kim SW
    BMJ Open; 2015 Jun; 5(6):e006898. PubMed ID: 26063564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staging and managing patients with acromegaly in clinical practice: baseline data from the SAGIT® validation study.
    Giustina A; Bronstein MD; Chanson P; Petersenn S; Casanueva FF; Sert C; Houchard A; Melmed S
    Pituitary; 2019 Oct; 22(5):476-487. PubMed ID: 31338660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and quality of life responses to octreotide-LAR in acromegaly.
    Mangupli R; Camperos P; Webb SM
    Pituitary; 2014 Dec; 17(6):495-9. PubMed ID: 24178448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
    Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
    Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total score or subscales in scoring the acromegaly quality of life questionnaire: using novel confirmatory methods to compare scoring options.
    Felt JM; Depaoli SA; Pereira AM; Biermasz NR; Tiemensma J
    Eur J Endocrinol; 2015 Jul; 173(1):37-42. PubMed ID: 25872514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of Life and its Determinants in Patients With Treated Acromegaly: A Cross-Sectional Nationwide Study in China.
    Guo X; Wang K; Yu S; Gao L; Wang Z; Zhu H; Xing B; Zhang S; Dong D
    J Clin Endocrinol Metab; 2021 Jan; 106(1):211-225. PubMed ID: 33079177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.